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ABSTRACT 
 
Oral leukoplakia is the most common potentially malignant oral lesion.  While the 
clinicopathological features in white patients are well characterised, this is not the case in 
black people.  The aim of this study is to analyse the differences in the clinicopathological 
features of oral leukoplakia in different racial groups in the greater Johannesburg area of 
South Africa, with special emphasis on the black population.  Only 14% of oral 
leukoplakia occurred in black persons compared to 80% in white persons.  In contrast to 
white persons, black persons were diagnosed with oral leukoplakia at a younger age; there 
were more males affected than females; and the proportion of idiopathic leukoplakias was 
greater.  There were significantly more black people (23%) with non-homogenous 
leukoplakia oral leukoplakia than white people with non-homogenous leukoplakia (13%), 
but there were significantly more white people (51%) than black people (23%) with 
dysplastic oral leukoplakia; and while in white people the floor of the mouth was the most 
frequently affected site, in black people it was the buccal mucosa. This study provides 
important differences in the clinicopathological features of oral leukoplakia between black 
persons and white persons.  
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CHAPTER 1 
 
1. INTRODUCTION 
 
Oral leukoplakia, the most common potentially malignant lesion of the oral cavity, is a 
white plaque that cannot be characterised clinically or histopathologically as any other 
specific entity and is not associated with any aetiological factor other than tobacco/areca 
nut use (1). 
 
Older age, certain anatomical sites, high-grade epithelial dysplasia and lesional 
keratinocytes carrying DNA aneuploidy and/or loss of heterozygosity of certain 
chromosomal loci, are factors associated with a heightened risk of malignant 
transformation of leukoplakic lesions (2-4). 
 
Based on the clinical appearance, oral leukoplakia can be classified into two main types, 
homogenous and non-homogenous.  Non-homogenous leukoplakia can be further sub-
classified into erythroleukoplakia, nodular and verrucous forms (1).  Both homogenous 
leukoplakia and non-homogenous leukoplakia can clinically present as a single lesion or 
multiple lesions.  Multiple lesions may affect a single oral-site or concurrently different 
oral sites. 
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Between 70% - 90% of oral leukoplakias are associated with tobacco use, and there is a 
close relationship between the amount and duration of cigarette, pipe and cigar smoking 
and the frequency of oral leukoplakia (5).  Upon cessation of the habit, tobacco smoking-
related oral leukoplakia may regress or resolve.  Although there is a clear association 
between tobacco smoking and the development of oral leukoplakia and similarly between 
tobacco smoking and oral squamous cell carcinoma (SCC), tobacco smoking seems to be a 
poor predictor for the progression of oral leukoplakia to oral SCC (2). 
 
The estimated prevalence of oral leukoplakia world-wide ranges from 0.5% to 3.46% (6). 
About 90% of all oral leukoplakia are tobacco related and the remainder are idiopathic (2). 
Oral leukoplakia more often affects males than females, is uncommon before middle-age 
and the prevalence is found to increase with age (5). With decreasing order of frequency, 
oral leukoplakia affects the buccal mucosa, the lower gingiva, the tongue and the floor of 
the mouth (2). 
 
The overall risk of malignant transformation of oral leukoplakia is about 2%.  Between 
0.6% and 5% of homogenous leukoplakia and between 20-25% of non-homogenous 
leukoplakia unpredictably undergo malignant transformation (2, 7) and it is estimated that 
between 17% and 35% of oral SCC arise from pre-existing oral leukoplakia.  The 
remaining oral SCC arise de novo from apparently normal oral epithelium (6). 
 
It is becoming increasingly evident that most oral leukoplakias arise within precancerised 
oral epithelial fields of genetically altered keratinocytes.  However, clinically it is 
impossible to distinguish oral leukoplakia evolving within a benign epithelial field from 
leukoplakia arising from precancerous epithelial fields.  The concept of field cancerisation 
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explains why some oral leukoplakias may occur concurrently in the same subject, why 
some leukoplakias progress to oral SCC, and why some oral leukoplakias recur despite 
treatment (8). 
 
Histopathologically oral leukoplakia may show hyperplasia with or without dysplasia, 
different degrees of dysplasia, or carcinoma in situ. 
 
The epidemiology and demographics of oral leukoplakia in black persons is not well 
understood.  One study from South Africa showed 86% of persons with oral leukoplakia 
were white, 9% were black and 5% were asian despite the fact that the vast majority of the 
South African population is black (9).  This apparent low prevalence of oral leukoplakia in 
black South Africans is difficult to explain.  This may be due to the fact that in the pre- 
1994 era, black people had limited access to government health facilities, that black 
persons in South Africa smoke less compared to other South African population groups, 
and that in general, black people seek medical treatment late in the course of their disease 
and by the time of diagnosis, the oral leukoplakia has already transformed into oral SCC 
(10, 11). It is however possible that for reasons unknown, the prevalence of oral 
leukoplakia in South African blacks is inherently low.   
 
Therefore a study investigating the clinical and histopathological features of oral 
leukoplakia in different racial population groups in South Africa may shed some light to 
whether oral leukoplakia in black South Africans is comparable to other racial population 
groups.  
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CHAPTER 2 
2. LITERATURE REVIEW 
 
2.1 Definition, epidemiology and aetiopathogenesis 
 
The term ‘leukoplakia’ was coined in 1877 by Schwimmer to describe a white lesion of the 
tongue (12). The definition of leukoplakia has undergone several modifications since then 
with the intention of standardising diagnostic criteria in order to improve the 
communication between clinicians and pathologists, to standardise treatment modalities 
and to facilitate research (1). Currently, oral leukoplakia is defined as a white patch that 
cannot be characterised clinically or microscopically as any other specific entity and is not 
associated with any aetiological agent other than tobacco/ areca nut use (1, 5, 13).  
 
Based on clinical examination, a diagnosis of leukoplakia is made when all known lesions 
of similar appearance are excluded (Table I) and after a histological examination could not 
identify any other known entities (1, 13). 
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Table I: Clinical differential diagnosis of leukoplakia (14) 
Aspirin burn  
Candidiasis, pseudomembranous   
Candidiasis, hyperplastic  
Frictional lesion   
Hairy leukoplakia   
Leukoedema   
Linea alba   
Lupus erythematosus   
Morsicatio (habitual chewing or biting of the cheek, tongue, lips) 
Papilloma and allied lesions   
Syphilis, secondary (‘‘mucous patches”)  
Tobacco-induced lesions(palatal lesions in reverse smokers) 
Smoker’s palate (nicotinic stomatitis)  
Snuff induced lesion  
White sponge nevus 
 
There are only few studies in the literature that report the incidence rate of oral 
leukoplakia. The first study conducted in a rural village setting in India reported an age- 
adjusted incidence rate for oral leukoplakia of 240 per 100,000 persons/year in males and 3 
per 100,000 persons/year in females (15-17). The second study conducted in a city in Japan 
reported an incidence rate of 409 per 100,000 persons/year in males and 70 per 100,000 
persons/year in females (16). 
 
The reported prevalence of leukoplakia in the world population varies from less than 1% to 
more than 5% (18, 19). Worldwide, the pooled prevalence obtained from systematic 
reviews was estimated between 1.49% and 4.27% (6). The prevalence of leukoplakia 
varies in different parts of the world, being higher in the Indian subcontinent than in 
Western countries. Scheifele et al (20) reviewed data from studies conducted during the 
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years 1985—2002 (number the individuals examined exceeding 500) and reported that the 
prevalence of oral leukoplakia ranges from 0.6 to 3.1% (Table II). In the United States, the 
prevalence of oral leukoplakia is 2.9 in white Americans over 35 years of age (21). A more 
recent study from the United States estimated the prevalence to be 0.4 which is 
considerably lower compared to previous studies (20). The prevalence and incidence of 
oral leukoplakia among black persons in South Africa is unknown. 
 
Table II: Prevalence of oral leukoplakia in different countries 
 
(studies published 1985—2002 with n>500)  (20) 
Country Year Participants Prevalence of OL (%) 
Saudi Arabia 1985 674 1.9 
USA 1986 23,616 2.9 
Netherlands 1988 1000 1.4 
Sweden 1990 920 1.9 
Hungary 1991 7820 1.3 
Japan 1991 3131 2.5 
Cambodia 1995 1319 1.1 
Netherlands 1996 1000 0.6 
Netherlands 1996 1000 0.2 
Germany 1996 1000 0.9 
Argentina (Cordoba) 1997 4183 6.8 
Argentina (Buenos Aires) 1997 4838 2.8 
Malaysia 1997 11,707 1.0 
India 2000 49,179 2.3 
Yugoslavia 2000 2385 2.2 
Slovenia 2000 555 3.1 
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Oral leukoplakia may be idiopathic or may be associated with tobacco/areca nut use (1, 
22). The role of tobacco in the pathogenesis of oral leukoplakia has been extensively 
reported (6, 12, 17, 23, 24). Although, tobacco smoke seems to be an important agent 
implicated in the pathogenesis of oral leukoplakia, its pathogenic role cannot be 
established in all cases. In certain geographic areas like the Indian subcontinent, tobacco 
and areca nut use, either alone or in combination, account for most cases of oral 
leukoplakia (2, 6, 15). Betel quid chewing (a combination of areca nut, betel leaves and 
slaked lime) is common practice in Asia and among migrated asian communities in Africa, 
Europe and North America (25). Smoking tobacco in the form of cigarettes is an important 
risk factor for leukoplakia in the developed world (19, 26). In Sweden, where snuff dipping 
was common practise, a survey found white oral patches in 24.8% of the population and 
reported that snuff dipping caused the lesions in 7.2% of cases (27). However, there are 
researchers who do not include snuff-induced lesions under the umbrella of oral 
leukoplakia since the malignant potential and the clinical course of snuff keratosis are 
different from those of oral leukoplakia (5, 14). 
 
Human papilloma virus (HPV) infection has been implicated in the pathogenesis of HPV-
cytopositive oral leukoplakia, specifically proliferative verrucous leukoplakia (28). The 
rate of HPV detection in oral potentially malignant lesions show extreme variations 
probably owing to differences in the geographic locations, ethnicity, sample size and in the 
methods of tissue detection (29-31). Miller and Johnstone (31) also reported an increased 
frequency of HPV in oral dysplastic epithelium in comparison with normal mucosa. 
However the exact role which HPV-genotypes play in the pathogenesis of oral leukoplakia 
is unknown.  
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2.2 Clinical characteristics 
 
Leukoplakic lesions tend to occur in people over the age of 30 years (32, 33). The gender 
distribution of leukoplakia is 1:1 except in some geographical areas like the Indian 
subcontinent where males are more frequently affected, probably because they use 
tobacco/areca nut more than females (32, 33). Oral leukoplakia may occur as a single 
lesion, as multiple lesions or as diffusely widespread lesions (33, 34). The proposed 
classification and staging system for oral leukoplakia based on the size of the lesion is 
shown in Table III (34). Theoretically, the site affected should relate to the region of the 
oral cavity in contact with the mutagenic agent. The site affected thus varies in different 
parts of the world (15, 33). However, in many cases these agents are unknown. It is 
possible that in some cases, precancerous oral leukoplakia may arise from spontaneously 
induced cytogenetic alterations in oral keratinocytes (8, 35). 
 
Table III: Proposed classification and staging system for oral leukoplakia (36) 
L- Classification of size of oral leukoplakia 
L1     Size of single or multiple leukoplakias together <2 cm 
L2     Size of single or multiple leukoplakias together 2-4 cm 
L3     Size of single or multiple leukoplakias together >4 cm 
L4     Size not specified 
P-Pathology 
P0 No epithelial dysplasia (includes ‘‘no or perhaps mild epithelial dysplasia’’; equals OIN grade 0) 
P1 Distinct epithelial dysplasia (includes ‘‘mild to moderate’’ and ‘‘moderate to possibly severe’’ 
epithelial dysplasia; equals OIN grades 1 and 2) 
P‘x Absence or presence of epithelial dysplasia not specified in the pathology report 
OLEP staging system 
Stage I      L1P0 
Stage II          L2P0 
Stage III    L3P0 or L1L2P1 
Stage IV        L3P1 
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Clinically, oral leukoplakias are either homogenous or non-homogenous based on surface 
colour and/or morphological characteristics (1, 7). Homogeneous lesions are uniformly flat 
and may exhibit surface irregularities in the form of shallow cracks and are classified into 
flat, corrugated, wrinkled and pumice-like based on the surface appearance (1, 7, 37). The 
non-homogenous varieties include: 
• speckled: mixed, white and red, but retaining predominantly white character; 
• nodular: small polypoid outgrowths, rounded red or white excrescences; 
• verrucous: wrinkled or corrugated surface appearance; 
• proliferative verrucous leukoplakia (PVL): multiple, simultaneous leukoplakias, 
which tend to recur and have an aggressive course. 
 
The clinical appearance of leukoplakic lesions is variable and may change over time (12). 
Some homogenous oral leukoplakia may become larger or change its clinical appearance to 
non-homogenous, but most of the lesions will remain stable or regress (2). 
Erythroleukoplakia should be distinguished clinically from oral erythroplakia, a 
precancerous lesion that carries the greatest risk of malignant transformation amongst all 
other precancerous oral lesions (5). Proliferative verrucous leukoplakia, which is 
considered by some as a distinct clinical sub-type of oral leukoplakia is characterised by 
multiple concurrent lesions that frequently affect wide areas of the oral mucosa (1). 
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2.3 Histopathological features 
 
Squamous hyperplasia, hyperkeratosis and epithelial dysplasia, singularly or in 
combination are histopathological features commonly found in oral leukoplakia. Squamous 
hyperplasia refers to increased number of cells in the spinous layer or in the basal⁄parabasal 
cell layers and the architecture shows regular stratification without cellular atypia. 
Hyperkeratosis refers to the thickening of the stratum corneum and is often associated with 
a qualitative abnormality of the keratin. It may also be accompanied by an increase in the 
granular layer. Dysplasia refers to architectural disturbance accompanied by cytological 
atypia. A list of the dysplastic features is given in table IV.  
 
Table IV: Histopathological features of epithelial dysplasia (38) 
1 Loss of polarity 
2 Presence of more than one layer of cells having a basaloid appearance 
3 Increased nuclear cytoplasmic ratio 
4 Drop shaped rete processes 
5 Irregular epithelial stratification 
6 Increased number of mitotic figures (few abnormal mitoses may be present) 
7 Presence of mitotic figures in the superficial half of the epithelium 
8 Cellular pleomorphism 
9 Nuclear hyperchromatism 
10 Enlarged nucleoli 
11 Reduction of cellular cohesion 
12 Keratinisation of single cells or cell groups in the prickle layer 
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Epithelial dysplasia can be further classified into mild, moderate and severe. The grades of 
epithelial dysplasia and the histological features of carcinoma in situ are given in table V. 
 
Table V: Grades of dysplasia and features of carcinoma in situ (39) 
Mild dysplasia 
Architectural disturbance limited to the lower third of the epithelium, accompanied by minimal 
cytological atypia 
Moderate dysplasia 
Architectural disturbance extending into the middle third of the epithelium  
The presence of marked atypia may indicate that a lesion should be categorised as severe dysplasia 
despite not extending into the upper third of the epithelium. 
Severe dysplasia 
Recognition of severe dysplasia starts with greater than two thirds of the epithelium showing 
architectural disturbance with associated cytological atypia.  
Carcinoma in situ 
Recognition of severe dysplasia starts with full thickness or almost full thickness architectural 
abnormalities in the viable cellular layers accompanied by pronounced cytological atypia.  Atypical 
mitotic figures and abnormally superficial mitoses are commonly seen in carcinoma in situ. 
 
Epithelium with moderate and severe dysplasia is two times more likely to undergo 
malignant transformation than epithelium with mild dysplasia or hyperplasia (40, 41). 
Non-homogenous leukoplakia is more likely to be dysplastic than the epithelium of 
homogenous leukoplakia. 
 
Grading of epithelial dysplasia is highly subjective and there is considerable inter-
examiner and intra-examiner variability (39). Moreover an incisional biopsy of an affected 
site may not be representative of the whole lesion in terms of dysplastic changes (42). 
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Therefore, although an important and useful indicator to assess the malignant potential of a 
lesion, epithelial dysplasia is a poor predictor for cancerous transformation. 
 
2.4 Diagnosis of oral leukoplakia 
 
A provisional clinical diagnosis of oral leukoplakia is made when a white lesion cannot be 
characterised clinically as any other specific pathological entity and is not associated with 
any aetiological agent other than tobacco or areca nut use. A definitive diagnosis of oral 
leukoplakia is established after provisional clinical diagnosis of oral leukoplakia has been 
made and the lesion cannot be characterised microscopically as any other specific 
pathological entity. Thus a definitive diagnosis of oral leukoplakia is established by 
exclusion of other entities on clinical and histopathological grounds (8). A biopsy is 
mandatory not only to exclude other disease entities but also to ensure that the lesion is not 
squamous cell carcinoma, and to establish the presence or absence of epithelial dysplasia 
(22). 
 
2.5 The malignant potential of oral leukoplakia 
 
Leukoplakia is the most common premalignant lesion of the oral mucosa (1, 37, 43). The 
risk of malignant transformation of oral leukoplakia is relatively low, and in most cases 
unpredictable (5, 34). The reported rates of malignant transformation of oral leukoplakia 
vary among studies, ranging from less than 1% to about 20%, probably owing to 
differences between the studies with regard to case selection criteria (hospital-based patient 
population, house to house surveyors, etc.), to geographic areas, to ethnic groups 
investigated, to tobacco use, to the time of follow-up, and to diagnostic criteria (7, 18). 
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Moreover, the reported rates of malignant transformation of oral leukoplakia, do not 
distinguish between treated oral leukoplakia (and different treatment modalities) and 
untreated cases, thus affecting the reliability of the reported results (7). 
Non-homogenous leukoplakia has a greater risk of progression to carcinoma than 
homogenous leukoplakia (2, 5). The estimated rate of malignant transformation of 
homogenous leukoplakia is 0.6 – 5% and of non-homogenous leukoplakia is 20 – 25% (2, 
5); and it is estimated that the overall lifetime risk of malignant transformation of oral 
leukoplakia is less than 2% per year (2).  
 
Additional clinical parameters associated with increased malignant potential of oral 
leukoplakia are the anatomical oral sub-sites in which they arise and the size of the lesion. 
In general, leukoplakia of the floor of the mouth, of the ventrolateral tongue and the soft 
palate are considered to show a higher-risk of malignant transformation than other 
anatomical sub-sites (2, 3); and it is suggested that large oral leukoplakic lesions carry a 
higher rate of malignant transformation than smaller size lesions (2, 7). 
 
At a molecular level the development of oral leukoplakia and its carcinomatous 
transformation is associated with loss of heterozygosity (LoH) at certain specific 
chromosomal loci, and DNA aneuploidy (35). Leukoplakic lesions of the floor of the 
mouth, of the ventrolateral surface of the tongue and of the soft palate have a higher risk of 
carcinomatous transformation and it is at these sites that the keratinocytes show increased 
LoH (35, 44). 
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If the chromosomes in the DNA are not uniformly distributed to the daughter cells or if 
parts of chromosomes become detached, the chromosomal segregation during mitosis is 
unbalanced. This is termed aneuploidy (40). The presence of aneuploidy in leukoplakia is 
one of the most predictable indicators of malignant transformation (45). Leukoplakia with 
keratinocytes showing DNA aneuploidy have higher carcinomatous transformation 
potential than those with normal diploid DNA content (35). 
 
The concept of field precancerization can explain why oral leukoplakia may develop at a 
single oral site or at multiple oral sites and why it may recur at the same site from which it 
was previously successfully excised. A field of precancerization in the oral cavity can be 
defined as an area of clinically normal-looking epithelium which is either microscopically 
normal or shows dysplasia; but in which some keratinocytes have undergone cytogenetic 
alterations. Leukoplakia and other premalignant lesions originating within the oral 
epithelium (i.e. erythroplakia) may be a clinical manifestation of such precancerised 
epithelial fields (8, 35). 
 
Accumulation of additional cytogenic alterations to initially transformed keratinocytes in 
such a field of precancerised oral epithelium could bring about progression of the existing 
premalignant leukoplakia to squamous cell carcinoma, or the de novo development of 
squamous cell carcinoma (8, 35). Depending on whether the transformed keratinocytes 
evolved from one progenitor basal cell that underwent clonal expansion, or evolved from 
several progenitor basal cells that underwent independent initial transformation and 
subsequent clonal expansion, the leukoplakia can be of a monoclonal or a polyclonal 
molecular profile (35). The time for the progression of leukoplakia within a field of 
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precancerised epithelial fields to squamous cell carcinoma if it ever does, may on average 
be 5 to 8 years (46). 
 
However, not all oral leukoplakias have malignant potential. In fact the majority of 
leukoplakia arises within benign fields of oral epithelium and others regress or remain 
stable. However, it is impossible to distinguish benign oral leukoplakia from premalignant 
leukoplakia (35). 
 
2.6 Treatment 
 
Smoking is a major risk factor for oral leukoplakia and hence managing leukoplakia would 
include cessation of smoking and avoidance of other possible associated risk factors 
(alcohol, high-risk sexual behaviour associated with HPV infection). There are different 
treatment options for leukoplakia, including observation and monitoring, surgical excision, 
cryotherapy and laser therapy (Table VI). Complete excision of the lesion is recommended 
if the lesion occurs on the ventral/lateral tongue, floor of the mouth, soft palate and 
oropharynx especially in the presence of dysplasia (47). However, the risk of malignant 
transformation is not completely eliminated by any of the current therapies.  
Table VI: Treatment options for leukoplakia (47) 
Surgical excision  
Laser surgery Electrocautery  
Retinoids Vitamin A Vitamin E fi-carotene  
Topical bleomycin  
Cryosurgery  
Photodynamic therapy  
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The treatment guidelines are given in table VII. 
 
Table VII: Treatment guidelines for oral leukoplakia (47) 
Eliminate all contributing factors  
Absence of dysplasia or presence of mild dysplasia  
Surgical excision/laser surgery of lesions on the ventral/lateral tongue, floor of the mouth, soft palate, 
oropharynx Close observation and follow-up for all other anatomic locations  
Presence of moderate or severe dysplasia  
Surgical excision or laser therapy are preferred treatments  
Red lesions (erythroplakia or leukoerythroplakia)  
Surgical excision 
Proliferative verrucous leukoplakia  
Surgical excision/laser surgery if possible  
Regular follow-up is highly recommended 
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CHAPTER 3 
 
3. AIMS AND OBJECTIVES 
 
Aim 
The aim of this study is to analyse the differences in the clinicopathological features of oral 
leukoplakia among different racial groups in the greater Johannesburg area of South 
Africa, with special emphasis on the black population. 
 
 
The objectives of the study are 
1. To determine the age, gender, ethnicity, site of the lesion, habits, clinical types and 
histopathological diagnosis of leukoplakia cases. 
2. To determine the association between the age, gender, site of the lesion, habits, clinical 
types, histopathological diagnosis and the ethnicity of the patient. 
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CHAPTER 4 
 
4. MATERIALS AND METHODS 
4.1 Sample size and selection of participants 
The histopathological reports of all cases diagnosed clinically as oral leukoplakia and 
histologically as hyperkeratosis without dysplasia, hyperkeratosis with mild, moderate or 
severe dysplasia, and carcinoma in situ over a 21 year period (1990 – 2010) were retrieved 
from the archives of the Division of Oral Pathology at the University of Witwatersrand, 
Johannesburg.   
 
4.2 Clinical evaluation 
Clinical data with regard to age, gender, race, clinical appearance (homogenous or non-
homogenous leukoplakia), number of leukoplakic lesions, site of the lesion in the mouth, 
and tobacco use were recorded. When the information was incomplete in the 
histopathological reports, the required information was obtained from the patients clinical 
records. The retrieved information was entered onto a data collection form (Appendix 1).   
 
4.3 Histological evaluation 
The haematoxylin and eosin (H&E) stained sections of each case diagnosed with oral 
leukoplakia was reviewed by the researcher in conjunction with an oral pathologist using a 
dual headed microscope [Nikon Eclipse 80i (Nikon Corp, Tokyo, Japan)] fitted with 10x 
oculars and a 40x objective to confirm the diagnosis.   
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4.4 Inclusion criteria 
 
 Cases that were included in the study were those diagnosed clinically with oral 
leukoplakia and histologically as hyperkeratosis without dysplasia, hyperkeratosis 
with mild, moderate or severe epithelial dysplasia and carcinoma in situ. 
 In cases with multiple biopsies for recurrent leukoplakic lesions, only the first 
biopsy report was included. 
 In cases with multiple lesions, the lesion that was biopsied first was included. 
 
4.5 Exclusion criteria 
 
 Cases with insufficient clinical data to confirm a clinical diagnosis of oral 
leukoplakia. 
 Cases diagnosed clinically as oral leukoplakia but on histopathological examination 
were found to be squamous cell carcinoma. 
 Cases in which a cause for the hyperkeratosis was apparent, for example friction, 
candidiasis and snuff use. 
 
4.6 Ethical considerations 
The ethics code M080850 used for this research adheres to international ethical criteria for 
research. This is a blanket code for use on archival block material obtained from human 
tissues allocated to the Division of Oral Pathology, Department of Anatomical Pathology 
and covers the review of the histological sections.   
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An ethics clearance certificate No: M110614 (Appendix 2) was obtained from the Human 
Research Ethics Committee (Medical) of the University of the Witwatersrand, 
Johannesburg to view patient’s hospital files in order to obtain clinical data needed for the 
study. Permission to access the clinical records of the patients was obtained from the CEO 
of Charlotte Maxeke Johannesburg Academic Hospital (Appendix 3). The identity of the 
patient was kept confidential.  
 
4.7 Statistical analysis 
 
The data obtained was entered into Microsoft
®
 Excel
®
 spreadsheets and then transferred to 
the statistical software programme IBM
® 
SPSS
® 
Statistics, version 20.0 (IBM Corporation, 
New York2011) for statistical analysis under the guidance of the statistician Mr Charles 
Chimedza. Chi-squared tests, t-tests, binomial-distribution tests and binary logistical 
regression was computed to conduct statistical hypothesis tests and to explore differences 
among histopathological and clinical parameters of oral leukoplakia between blacks, 
coloureds, asians and whites.  p-values of 0.05 or less was considered as statistically 
significant. 
 
When performing binary logistical regression analysis, the categorical variables namely: 
age, gender, site, ethnicity, and smoking habit were computed to the outcome (dependent) 
variables namely: the clinical classification of leukoplakia and the presence of epithelial 
dysplasia. Hosmer and Lemeshow test was done to check ‘goodness-of-fit’ of the model.  
 
There were only few asians and coloureds in the study and the comparisons are thus 
between the white and black patients. When computing chi-squared tests and logistical 
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regression analysis, the data was filtered to include only white and black patients even 
though the asians and coloureds are represented in the results section. 
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CHAPTER 5 
5. RESULTS 
 
There were a total of 21,300 biopsy specimens submitted for histopathological examination 
to the Oral Pathology Department at the University of Witwatersrand for the 21 year period 
from 1990-2010 (Table VIII). One hundred and forty-three biopsy reports were found to 
have a histopathological diagnosis of hyperkeratosis with or without dysplasia and a 
clinical diagnosis of oral leukoplakia. The histopathological findings of these cases were 
re-examined by a specialist in oral pathology (Prof Shabnum Meer) and the researcher. 
Two reports were excluded owing to the presence of candida infection. Thirty-three cases 
were excluded as there was insufficient clinical data to confirm a clinical diagnosis of oral 
leukoplakia. Furthermore, data with regard to family history of cancer was incomplete or 
unreliable and was therefore not used for statistical analysis. 
 
Nine of the 143 biopsy reports were repeat biopsies of recurrent lesions. In these cases only 
the first biopsy report was included in the statistical analysis. Five of the 95 patients had 
multiple oral lesions but only one lesion was biopsied and sent for microscopical 
examination. Another five cases had multiple oral lesions sent for microscopical 
examination of which only the first lesion examined was included in the study. After re-
examination and exclusion of the above mentioned cases, a total of 95 cases were included 
in the study (Table VIII). 
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Table VIII Case distribution per year 
Year Total cases biopsied Cases selected Percent 
1990 670 14 14.7 
1991 764 12 12.6 
1992 756 6 6.3 
1993 725 13 13.7 
1994 602 4 4.2 
1995 824 4 4.2 
1996 661 5 5.3 
1997 636 10 10.5 
1998 442 3 3.2 
1999 1066 2 2.1 
2000 1134 3 3.2 
2001 1184 1 1.2 
2002 1382 2 2.2 
2003 1477 2 2.2 
2004 1380 3 3.2 
2005 1294 0 0.0 
2006 1086 2 2.1 
2007 1004 3 3.2 
2008 1124 3 3.2 
2009 1618 0 0.0 
2010 1471 3 3.2 
 21300 95 100 
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5.1 Age, gender and ethnicity 
 
There was a wide age distribution of cases occurring from the 3rd to the 9th decades with 
most cases occuring in the 5
th
 and the 6
th 
decade (Table IX). The mean age of the patients 
at the time of diagnosis was 50 years (standard deviation of 12.94, range 21-80). The mean 
age at the time of diagnosis was 48 years for men (standard deviation: 13.57) and 52 
years for women (standard deviation: 12.13). This difference was not statistically 
significant (p-value=0.288). There was an equal gender distribution (M:F=48:47) (Table 
IX). 
 
Table IX: Age in relation to gender 
Age group Male (n=48) Female (n=47) Total (n=95) 
20-29 4 (8.3%) 1 (2.1%) 5 (5.3%) 
30-39 9 (18.8%) 7 (14.9%) 16  (16.8%) 
40-49 13 (27.1%) 11 (23.4%) 24 (25.3%) 
50-59 11 (22.9%) 14 (29.8%) 25 (26.3%) 
60-69 8 (16.7%) 9 (19.1%) 17  (17.9%) 
70-79 2 (4.2%) 5 (10.6%) 7  (7.4%) 
80-89 1 (2.1%) 0 (0.0%) 1  (1.1%) 
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Most of the patients (76) were white (80%). Thirteen patients (13.7%) were black, five 
patients were asian (5.3%) and one patient (1%) was coloured (Table X). When relating the 
gender to the ethnicity of the patients, there were more white females than white males 
with oral leukoplakia (F: M=10:9), but there were more black males than black females 
with oral leukoplakia (F: M= 5:8) (Table X). Black patients were diagnosed with oral 
leukoplakia at a younger age (47 years, standard deviation: 12.39) than white patients (51 
years, standard deviation: 13.05), however this was not statistically significant (p-
value=0.508). 
 
Table X: Gender and age in relation to ethnicity 
  White (n=76) Black (n=13) Asian (n=5) Coloured (n=1) Total (n=95) 
Age 20-29 4 (5.3%) 1 (7.7%) 0 (0.0%) 0 (0.0%) 5 (5.3%) 
(years) 30-39 12 (15.8%) 2 (15.4%) 2 (40.0%) 0 (0.0%) 16 (16.8%) 
 40-49 18 (23.7%) 5 (38.5%) 1 (20.0%) 0 (0.0%) 24 (25.3%) 
 50-59 21 (27.6%) 3 (23.3%) 1 (20.0%) 0 (0.0%) 25 (26.3%) 
 60-69 14 (18.4%) 1 (7.7%) 1 (20.0%) 1 (100%) 17 (17.9%) 
 70-79 6 (7.9%) 1 (7.7%) 0 (0.0%) 0 (0.0%) 7 (7.4%) 
 80-89 1 (1.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.1%) 
Gender Male 36 (47.9%) 8 (61.5%) 3  (60.0%) 1  (100%) 48 (50.5%) 
 Female 40  (52.6%) 5 (38.5%) 2 (40.0%) 0 (0.0%) 47 (49.5%) 
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5.2 Oral site distribution 
 
The most commonly affected site was the floor of the mouth, followed by the buccal 
mucosa and the lateral aspect of the tongue (Table XI). There was no difference with 
regard to the site affected by leukoplakia in men and women. 
 
Table XI: Site in relation to gender 
   Male (n=48) Female (n=47) Total (n=95) 
Buccal mucosa 8 (16.7%) 10 (21.3%) 18 (18.9%) 
Alveolar ridge 3 (6.2%) 6 (12.8%) 9 (9.5%) 
Floor of the mouth 12 (25.0%) 13 (27.7%) 25 (26.3%) 
Retro molar pad 3 (6.2%) 1 (2.1%) 4 (4.2%) 
Lateral tongue 7 (14.6%) 7 (14.9%) 14 (14.7%) 
Ventral tongue 2 (4.2%) 2 (4.3%) 4 (4.2%) 
Gingiva 5 (10.4%) 3 (6.4%) 8 (8.4%) 
Soft palate 3 (6.2%) 3 (6.4%) 6 (6.3% 
Hard palate 3 (6.2%) 0 (0.0%) 3 (3.2%) 
Lower lip 2 (4.2%) 1 (2.1%) 3 (3.2%) 
Commissure of the lip 0 (0.0%) 1 (2.1%) 1 (1.1%) 
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When comparing white to black patients, in white patients with oral leukoplakia, the most 
frequently affected site was the floor of the mouth followed by the lateral aspect of the 
tongue, while in black patients with oral leukoplakia; the buccal mucosa was the most 
affected site (Table XII).  
 
Table XII: Site in relation to ethnicity 
 White (n=76) Black (n=13) Asian (n=5) Coloured (n=1) Total (n=95) 
Buccal mucosa 10 (13.2%) 6 (46.2%) 2 (40.0%) 0 (0.0%) 18 (18.9%) 
Alveolar ridge 8 (10.5%) 1 (7.7%) 0 (0.0%) 0 (0.0%) 9 (9.5%) 
Floor of the mouth 23 (30.3%) 1 (7.7%) 0 (0.0%) 1 (100.0%) 25 (26.3%) 
Retro molar pad 2 (2.6%) 2 (15.4%) 0 (0.0%) 0 (0.0%) 4 (4.2%) 
Lateral tongue 13 (17.1%) 0 (0.0%) 1 (20.0%) 0 (0.0%) 14 (14.7%) 
Ventral tongue 2 (2.6%) 1 (7.7%) 1 (20.0%) 0 (0.0%) 4 (4.2%) 
Gingiva 8 (10.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 8 (8.4%) 
Soft palate 5 (6.6%) 1 (7.7%) 0 (0.0%) 0 (0.0%) 6 (6.3%) 
Hard palate 3 (3.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (3.2%) 
Lower lip 1 (1.3%) 1 (6.7%) 1 (16.7%) 0 (0.0%) 3 (3.2%) 
Commissure of the lip 1 (1.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.1%) 
 
 
The data with regard to the extent of the leukoplakic lesions was incomplete or unreliable 
and was therefore not used for statistical analysis.  
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5.3 Habits 
 
The habits that were investigated were tobacco smoking, alcohol consumption and betel 
nut use. The data with regard to alcohol consumption was incomplete or unreliable and 
was therefore not used for statistical analysis. The data with regard to betel nut use (2 
patients) and duration of smoking was excluded as it was incomplete. 
 
The relation of tobacco smoking to the different variables investigated is shown in table 
XIII. Seventy-eight percent (74/95) of the patients were tobacco smokers. The mean age of 
smokers at the time of diagnosis of oral leukoplakia (49 years, standard deviation: 13.05) 
was lower than the non-smokers (54 years, standard deviation: 12.02), but this was not 
statistically significant (p-value=0.815). More males (85.4%, 41/48) with oral leukoplakia 
smoked than females (70.2%, 33/47) with oral leukoplakia. In smokers the most frequently 
affected site was the floor of the mouth followed by the buccal mucosa, while in non-
smokers the most commonly affected site was the lateral aspect of the tongue followed by 
the buccal mucosa.  
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Table XIII: Cross tabulation of smoking habit 
  Smokers (n=74) Non-smokers (n=14) Total (n=95) 
Age 20-29 5 (6.8%) 0 (0.0%) 5 (5.3%) 
(years) 30-39 13 (17.6%) 3 (14.3%) 16 (16.8%) 
 40-49 19 (25.7%) 5 (23.8%) 24 (25.3%) 
 50-59 21 (28.4%) 4 (19.0%) 25 (26.3%) 
 60-69 10 (13.5%) 7 (33.3%) 17 (17.9%) 
 70-79 5 (6.8%) 2 (9.5%) 7 (7.4%) 
 80-89 1 (1.4%) 0 (0.0%) 1 (1.0%) 
Gender Male 41 (55.4%) 7 (33.3%) 48 (50.5%) 
 Female 33 (44.6%) 14 (66.7%) 47 (49.5%) 
Site Buccal mucosa 14 (18.9%) 4 (19.0%) 18 (18.9%) 
 Alveolar ridge 9 (12.2%) 0 (0.0%) 9 (9.5%) 
 Floor of the mouth 24 (32.4%) 1 (4.8%) 25 (26.3%) 
 Retro molar pad 4 (5.4%) 0 (0.0%) 4 (4.2%) 
 Lateral tongue 6 (8.1%) 8 (38.1%) 14 (14.7%) 
 Ventral tongue 2 (2.7%) 2 (9.5%) 4 (4.2%) 
 Gingiva 6 (9.5%) 2 (8.1%) 8 (8.4%) 
 Soft palate 4 (5.4%) 2 (9.5%) 6 (6.3%) 
 Hard palate 3 (4.1%) 0 (0.0%) 3 (3.2%) 
 Lower lip 1 (1.4%) 2 (9.5%) 3 (3.2%) 
 Commissure of the lip 1 (1.4%) 0 (0.0%) 1 (1.1%) 
 
In white patients, 82% (62/76) of the leukoplakic lesions were associated with smoking 
tobacco, while in black patients only 62% (8/13) of the leukoplakic lesions were associated 
with smoking tobacco (Table XIV).  
 
Table XIV: Smoking in relation to ethnicity 
 White (n=76) Black (n=13) Asian (n=5) Coloured (n=1) Total (n=95) 
Smokers 62 (81.6%) 8 (61.5%) 3  (60.0%) 1  (100%) 74 (77.9%) 
Non-smokers 14  (18.4%) 5 (38.5%) 2 (40.0%) 0 (0.0%) 21 (22.1%) 
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5.4 Clinical types of oral leukoplakia 
 
The frequencies of the different clinical types of oral leukoplakia in the study population 
are shown in table XV. Eighty-five percent (81/95) of the cases of oral leukoplakia were of 
the homogenous type and 15% (14/99) were of the non-homogenous type. Of the non-
homogenous leukoplakia, 50% (7/14) were erythroleukoplakia, 43% (6/14) were verrucous 
leukoplakia and 7% (1/14) were proliferative verrucous leukoplakia. 
 
Table XV: Clinical classification of leukoplakia 
 Total (n=95) Percent 
Homogenous leukoplakia 81 85.3 
Erythroleukoplakia 7 7.4 
Nodular leukoplakia 0 0 
Verrucous leukoplakia 6 6.3 
Proliferative verrucous leukoplakia 1 1.1 
 
 
The relation of homogenous and non-homogenous leukoplakia to the different variables 
investigated is shown in table XVI. The mean age at the time of diagnosis of homogenous 
and non-homogenous oral leukoplakia was 50 years (standard deviation: 12.53 and 15.62). 
Eighty-eight percent of males (42/48) and 83% of females (39/47) had homogenous 
leukoplakia. However there were more females (57%, 8/14) with non-homogenous 
leukoplakia than males (43%, 6/14) with non-homogenous leukoplakia. The floor of the 
mouth was the most frequently affected site in patients with homogenous and non-
homogenous leukoplakia. Eighty-eight percent (65/74) of the smokers had homogenous 
leukoplakia compared to 76% (16/21) of the non-smokers; and 12% (9/74) of the smokers 
had non-homogenous leukoplakia compared to 24% (5/21) of the non-smokers.  
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Table XVI: Cross tabulation of homogenous and non-homogenous leukoplakia 
  Homogenous (n=81) Non-homogenous (n=14) Total (n=95) 
Age Age: 20-29 4 (4.9%) 1 (7.1%) 5 (5.3%) 
(years) Age: 30-39 13 (16.0%) 3 (21.4%) 16 (16.8%) 
 Age: 40-49 22 (27.2%) 2 (14.3%) 24 (25.3%) 
 Age: 50-59 20 (24.7%) 5 (35.7%) 25 (26.3%) 
 Age: 60-69 17 (21.0%) 0 (0.0%) 17 (17.9%) 
 Age: 70-79 4 (4.9%) 3 (21.4%) 7 (7.4%) 
 Age: 80-89 1 (1.2%) 0 (0.0%) 1 (1.1%) 
Gender Male 42 (51.9%) 6 (42.9%) 48 (50.5%) 
 Female 39 (48.1%) 8 (57.1%) 47 (49.5%) 
Site Buccal mucosa 14 (17.3%) 4 (28.6%) 18 (18.9%) 
 Alveolar ridge 9 (11.1%) 0 (0.0%) 9 (9.5%) 
 Floor of the mouth 20 (24.7%) 5 (35.7%) 25 (26.3%) 
 Retro molar pad 4 (4.9%) 0 (0.0%) 4 (4.2%) 
 Lateral tongue 13 (16.0%) 1 (7.1%) 14 (14.7%) 
 Ventral tongue 2 (2.5%) 2 (14.3%) 4 (4.2%) 
 Gingiva 7 (8.6%) 1 (7.1%) 8 (8.4%) 
 Soft palate 5 (6.2%) 1 (7.1%) 6 (6.3%) 
 Hard palate 3 (3.7%) 0 (0.0%) 3 (3.2%) 
 Lower lip 3 (3.7%) 0 (0.0%) 3 (3.2%) 
 Commissure of the lip 1 (1.2%) 0 (0.0%) 1 (1.1%) 
Habit Smokers 65 (80.2%) 9 (64.3%) 74 (77.9%) 
 Non-smokers 16 (19.8%) 5 (35.7%) 21 (22.1%) 
 
 
There were more black people (23%) with non-homogenous leukoplakia than white people 
with non-homogenous leukoplakia (13%) (Table XVII). This association however was not 
significant (p-value=0.349). 
 
Table XVII: Relation of clinical classification and ethnicity 
 White (n=76) Black (n=13) Asian (n=5) Coloured (n=1) Total (n=95) 
Homogenous 66 (81.6%) 10 (61.5%) 4  (60.0%) 1  (100%) 81 (85.3%) 
Non-homogenous 10  (13.2%) 3 (23.1%) 1 (20.0%) 0 (0.0%) 14 (14.7%) 
 
 32 
 
The site affected in relation to the clinical subtypes of leukoplakia is shown in table XVIII. 
There were only few cases of the various type of non-homogenous leukoplakia for 
statistical analysis. 
 
Table XVIII: Site in relation to the clinical subtypes 
 Homogenous 
leukoplakia 
(n=81) 
Erythroleukoplakia 
(n=7) 
Verrucous 
leukoplakia 
(n=6) 
Proliferative 
verrucous 
leukoplakia 
(n=1) 
Total 
(n=95) 
Buccal mucosa 14 (17.3%) 1 (14.3%) 2 (33.3%) 1 (100%) 18 (18.9%) 
Alveolar ridge 9 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 9 (9.5%) 
Floor of the mouth 20 (24.7%) 2 (28.6%) 3 (50.0%) 0 (0.0%) 25 (26.3%) 
Retro molar pad 4 (4.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 4 (4.2%) 
Lateral tongue 13 (16.0%) 1 (14.3%) 0 (0.0%) 0 (0.0%) 14 (14.7%) 
Ventral tongue 2 (2.5%) 2 (28.6%) 0 (0.0%) 0 (0.0%) 4 (4.2%) 
Gingiva 7 (8.6%) 0 (0.0%) 1 (16.7%) 0 (0.0%) 8 (8.4%) 
Soft palate 5 (6.2%) 1 (14.3%) 0 (0.0%) 0 (0.0%) 6 (6.3%) 
Hard palate 3 (3.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (3.2%) 
Lower lip 3 (3.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (3.2%) 
Commissure of the lip 1 (1.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.1%) 
 
 
5.5 Histopathological diagnosis 
 
The presence of epithelial dysplasia in relation to the different variables investigated is 
shown in table XIX. Forty-seven percent (45/95) of the patients had dysplastic oral 
leukoplakia and 53% (50/95) had non-dysplastic oral leukoplakia. The mean age of the 
patients at the time of diagnosis of dysplastic oral leukoplakia (52 years, standard 
deviation: 13.69) was higher than for those diagnosed with non-dysplastic oral leukoplakia 
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(49 years, standard deviation: 12.21), but this was not statistically significant. Females 
(53.3%, 24/45) had more frequently than males (46.7%, 21/45) dysplastic oral leukoplakia.  
 
Dysplastic oral leukoplakia most frequently affected the floor of the mouth followed by the 
lateral aspect of the tongue while non-dysplastic oral leukoplakia affected most frequently 
the buccal mucosa followed by the floor of the mouth. Chi-squared tests revealed a 
significant relationship (p-value= 0.000) between the site affected and the presence of 
epithelial dysplasia. Binary logistic regression analysis revealed a significantly higher 
likelihood of the lateral aspect of the tongue (p-value =0.001), the floor of the mouth (p-
value= 0.003) and the buccal mucosa (p-value =0.017) to show presence of epithelial 
dysplasia.   
 
In smokers, forty-three percent (32/74) of the leukoplakic lesions had epithelial dysplasia 
while in non-smokers 62% (13/21) had epithelial dysplasia. This difference was not 
statistically significant (p-value=0.292). Forty-eight percent (39/81) of homogenous 
leukoplakia were dysplastic while only 42.8% (6/14) of non-homogenous leukoplakia were 
dysplastic. Fifty-two percent (42/81) of homogenous leukoplakia had no epithelial 
dysplasia while 57.1% (8/14) of non-homogenous leukoplakia had no epithelial dysplasia.  
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Table XIX: Cross tabulation of epithelial dysplasia 
Dysplasia  No dysplasia (n=50) Dysplasia (n=45) Total  (n=95) 
Age  20-29 3 (6.0%) 2 (4.4%) 5  (5.3%) 
(years) 30-39 8 (16.0%) 8 (17.8%) 16 (16.8%) 
 40-49 15 (30.0%) 9 (20.0%) 24 (25.3%) 
 50-59 15 (30.0%) 10 (22.2%) 25 (26.3%) 
 60-69 4 (8.0%) 13 (28.9%) 17 (17.9%) 
 70-79 5 (10.0%) 2 (4.4%) 7 (7.4%) 
 80-89 0 (0.0%) 1 (2.2%) 1 (1.1%) 
Gender Male 27 (54.0%) 21 (46.7%) 48 (50.5%) 
 Female 23 (46.0%) 24 (53.3%) 47 (49.5%) 
Site Buccal mucosa 16 (32.0%) 2 (4.4%) 18 (18.9%) 
 Alveolar ridge 5 (10.0%) 4 (8.9%) 9 (9.5%) 
 Floor of the mouth 9 (18.0%) 16 (35.6%) 25 (26.3%) 
 Retro molar pad 3 (6.0%) 1 (2.2%) 4 (4.2%) 
 Lateral tongue 1 (2.0%) 13 (28.9%) 14 (14.7%) 
 Ventral tongue 1 (2.0%) 3 (6.7%) 4 (4.2%) 
 Gingiva 7 (14.0%) 1 (2.2%) 8 (8.4%) 
 Soft palate 5 (10.0%) 1 (2.2%) 6 (6.3%) 
 Hard palate 1 (2.0%) 2 (4.4%) 3 (3.2%) 
 Lower lip 1 (2.0%) 2 (4.4%) 3 (3.2%) 
 Commissure of the lip 1 (2.0%) 0 (0.0%) 1 (1.1%) 
Habit Smokers 42 (84.0%) 32 (71.1%) 74 (77.9%) 
 Non-smokers 8 (16.0%) 13 (28.9%) 21 (21.1%) 
Leukoplakia Homogenous leukoplakia 42 (84.0%) 39 (86.7%) 81 (85.3%) 
 Non-homogenous leukoplakia 8 (16.0%) 6 (13.3%) 14 (14.7%) 
Clinical 
types 
Homogenous leukoplakia 42 (84.0%) 39 (86.7%) 81 (85.3%) 
Erythroleukoplakia 3 (6.0%) 4 (8.9%) 7 (7.4%) 
 Nodular leukoplakia 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Verrucous leukoplakia 4 (8.0%) 2 (4.4%) 6 (6.3%) 
 Proliferative verrucous  1 (2.0%) 0 (0.0%) 1 (1.1%) 
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Fifty-one percent (39/76) of the white patients with oral leukoplakia had epithelial 
dysplasia while only 23% (3/13) of the black patients with oral leukoplakia had epithelial 
dysplasia (Table XX). Chi-squared tests revealed a significant relationship (p-value= 
0.059) between ethnicity and the presence of epithelial dysplasia. 
 
Table XX: Relation of presence of epithelial dysplasia and ethnicity 
 White (n=76) Black (n=13) Asian (n=5) Coloured (n=1) Total (n=95) 
No dysplasia 37 (48.7%) 10 (76.9%) 2 (40.0%) 1 (100%) 50 (52.6%) 
Dysplasia 39 (51.3%) 3 (23.1%) 3 (60.0%) 0 (0.0%) 45 (47.4%) 
 
 
 
The different grades of epithelial dysplasia in relation to the different variables 
investigated, is shown in table XXI. Thirty-two percent (30/95) of the leukoplakic lesions 
had mild epithelial dysplasia, 14.7% (14/95) had moderate epithelial dysplasia and 1% 
(1/95) had severe epithelial dysplasia. Of the lesions with epithelial dysplasia, 66.7% 
(30/45) had mild epithelial dysplasia, 31.1% (14/45%) had moderate epithelial dysplasia 
and 2.2% (1/45) had severe dysplasia. There were no cases with a clinical diagnosis of 
leukoplakia that histopathologically showed features of carcinoma in situ.  
  
 36 
 
Table XXI: Cross tabulation of the grades of epithelial dysplasia  
  
No dysplasia 
(n=50) 
Mild 
dysplasia 
(n=30) 
Moderate 
dysplasia 
(n=14) 
Severe 
dysplasia 
(n=1) 
Total (n=95) 
Age  20-29 3 (6.0%) 2 (6.7%) 0 (0.0%) 0 (0.0%) 5  (5.3%) 
(years) 30-39 8 (16.0%) 5 (16.7%) 3 (21.4%) 0 (0.0%) 16 (16.8%) 
 40-49 15 (30.0%) 6 (20.0%) 3 (21.4%) 0 (0.0%) 24 (25.3%) 
 50-59 15 (30.0%) 7 (23.3%) 2 (14.3%) 1 (100%) 25 (26.3%) 
 60-69 4 (8.0%) 8 (26.7%) 5 (35.7%) 0 (0.0%) 17 (17.9%) 
 70-79 5 (10.0%) 1 (3.3%) 1 (7.1%) 0 (0.0%) 7 (7.4%) 
 80-89 0 (0.0%) 1 (3.3%) 0 (0.0%) 0 (0.0%) 1 (1.1%) 
Gender Male 27 (54.0%) 14 (46.7%) 7 (50.0%) 0 (0.0%) 48 (50.5%) 
 Female 23 (46.0%) 16 (53.3%) 7 (50.0%) 1 (100%) 47 (49.5%) 
Site Buccal mucosa 16 (32.0%) 2 (6.7%) 0 (0.0%) 0 (0.0%) 18 (18.9%) 
 Alveolar ridge 5 (10.0%) 4 (13.3%) 0 (0.0%) 0 (0.0%) 9 (9.5%) 
 Floor of the mouth 9 (18.0%) 13 (43.3%) 2 (14.3%) 1 (100%) 25 (26.3%) 
 Retro molar pad 3 (6.0%) 1 (3.3%) 0 (0.0%) 0 (0.0%) 4 (4.2%) 
 Lateral tongue 1 (2.0%) 5 (16.7%) 8 (57.1%) 0 (0.0%) 14 (14.7%) 
 Ventral tongue 1 (2.0%) 0 (0.0%) 3 (21.4%) 0 (0.0%) 4 (4.2%) 
 Gingiva 7 (14.0%) 1 (3.0%) 0 (0.0%) 0 (0.0%) 8 (8.4%) 
 Soft palate 5 (10.0%) 1 (3.0%) 0 (0.0%) 0 (0.0%) 6 (6.3%) 
 Hard palate 1 (2.0%) 1 (3.0%) 1 (7.1%) 0 (0.0%) 3 (3.2%) 
 Lower lip 1 (2.0%) 2 (6.7%) 0 (0.0%) 0 (0.0%) 3 (3.2%) 
 Commissure of the lip 1 (2.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.1%) 
Habits Smokers 42 (84.0%) 22 (73.3%) 9 (64.3%) 1 (100%) 74 (77.9%) 
 Non-smokers 8 (16.0%) 8 (26.7%) 5 (35.7%) 0 (0.0%) 21 (22.1%) 
Leukoplakia Homogenous  42 (84.0%) 26 (86.7%) 12 (85.7%) 1 (100%) 81 (85.3%) 
 Non-homogenous 8 (16.0%) 4 (13.3%) 2 (14.3%) 0 (0.0%) 14 (14.7%) 
Clinical Homogenous 42 (84.0%) 26 (86.7%) 12 (85.7%) 1 (100%) 81 (85.3%) 
types Erythroleukoplakia 3 (6.0%) 3 (10.0%) 1 (7.1%) 0 (0.0%) 7 (7.4%) 
 Nodular leukoplakia 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 Verrucous leukoplakia 4 (8.0%) 1 (3.3%) 0 (0.0%) 0 (0.0%) 5 (5.3%) 
 Proliferative verrucous 1 (2.0%) 0 (0.0%) 1 (7.1%) 0 (0.0%) 2 (2.1%) 
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The relation of the various grades of epithelial dysplasia in relation to ethnicity is given in 
table XXII. 
 
Table XXII: Cross tabulation of histopathological diagnosis and ethnicity 
 White (n=76) Black (n=13) Asian (n=5) Coloured (n=1) Total (n=95) 
No dysplasia 37 (48.7%) 10 (76.9%) 2 (40.0%) 1 (100%) 50 (52.6%) 
Mild dysplasia 27 (35.5%) 2 (15.4%) 1 (20.0%) 0 (0.0%) 30 (31.6%) 
Moderate dysplasia 11 (14.5%) 1 (7.7%) 2 (40.0%) 0 (0.0%) 14 (14.7%) 
Severe dysplasia 1 (1.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.1%) 
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CHAPTER 6 
6. DISCUSSION 
 
The data from this study on oral leukoplakia has been obtained from a biased sample of 
patients who had been consulted by dental practitioners for assessment of oral white 
lesions and had their biopsies microscopically examined. Therefore comparison of the data 
in this study with results of other studies of oral leukoplakia obtained by other selection 
criteria (house to house survey, hospital survey etc.) may not be applicable; and the results 
of this study with regard to the ethnic predilection of oral leukoplakia should be interpreted 
with caution since they may reflect a referral bias. 
 
In this study we excluded white lesions caused by snuff use since these lesions have a well-
known etiological agent (smokeless tobacco), and run a different course to that of oral 
leukoplakia, and therefore should be classified separately (12, 48). 
 
The epidemiology of oral leukoplakia in black persons is not well documented, but it 
appears that the frequency of oral leukoplakia in blacks is lower than in whites (9, 46). 
When evaluating biopsy reports of oral lesions with a histopathological diagnosis of 
epithelial dysplasia, Kaugars, Burns (49) reported that black persons accounted for about 
8% of cases while white persons for 91%; and Silverman, Gorsky (46) reported that of the 
257 patients with oral leukoplakia, 97% of them were whites. In a South African study of 
archived histopathological material, it was found that 86% of oral leukoplakia were from 
whites and 9% from blacks (9).  
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The methodology of the present study is similar to the South African study mentioned 
above, and in the present study 80% of oral leukoplakias were found in white patients, 
14% in black patients, 5% in asian patients and 1% in coloured patients (Table 3). The 
results of this study add further weight to the notion that in South Africa the frequency of 
oral leukoplakia in black persons is lower than in white persons (9), as it appears to be the 
case in the United States (46, 49). 
 
This low prevalence of oral leukoplakia in black South Africans is difficult to explain. 
While one can argue that during apartheid time (pre-1994) black people may have had 
limited access to government/provincial health facilities and therefore less patients were 
diagnosed with oral leukoplakia, in the post-1994 era, all South Africans regardless of their 
ethnic background have equal opportunities to receive medical care in 
government/provincial hospitals.  
 
The low frequency of oral leukoplakia in black persons may be attributed to the fact that in 
general, black persons seek medical treatment late in the course of their disease, and by the 
time of diagnosis, the oral leukoplakia has already undergone malignant transformation 
and progressed to oral squamous cell carcinoma (9, 50); and to the fact that in South 
Africa, black persons smoke tobacco less than do white persons (10, 11). Indeed, in this 
study, 62% of black patients with oral leukoplakia smoked tobacco compared to 82% of 
white patients with oral leukoplakia (Table VII). 
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This retrospective study of 95 patients with oral leukoplakia confirms other previous 
reports that oral leukoplakias usually occur between the fourth and seventh decades in life 
(2, 9, 33, 46); that oral leukoplakia may affect equally males and females (33, 51, 52); and 
that any site of the oral mucosa may be affected (2, 37, 46). While the buccal mucosa is the 
most frequently reported site affected by oral leukoplakia (2, 12, 46), in this study the floor 
of the mouth was the site most commonly affected. However data in the literature with 
regard to the sites affected by oral leukoplakia are highly variable owing to differences in 
factors such as selection criteria, methods of data collection and geographic location of the 
investigated population (8, 37, 52, 53). 
 
In this study, 78% of the oral leukoplakias were associated with tobacco smoking, 
conforming to reports in the literature that between 70% and 90% of oral leukoplakias are 
associated with tobacco smoking (9, 46, 54); and 85% of the cases were of the 
homogenous type, in line with other studies reporting that more than 60% of oral 
leukoplakias are of this type (9, 52). 
 
In this study, as it was also reported previously (9), there was no significant differences in 
site, clinical presentation (homogenous, non-homogenous) or in histological features 
between tobacco smoking associated and idiopathic leukoplakia (Table IX, XII, XIV). 
 
There are several clinical, histopathological and cytogenetic factors associated with a 
greater risk of malignant transformation of oral leukoplakia: older age, larger lesions, 
specific sites (floor of the mouth, ventrolateral surface of the tongue, maxillary retromolar 
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and adjoining soft palate), idiopathic lesions, non-homogenous lesions, high grade 
epithelial dysplasia and lesions in which the keratinocytes harbour cytogenetic alterations 
associated with malignant transformation (8, 12, 35, 37). 
 
The presence of epithelial dysplasia, particularly of the high-grade type, is an important 
indicator of possible future progression of the oral leukoplakia to squamous cell carcinoma 
(8, 14, 35, 37, 55). On reviewing the histopathological features of these study cases, 54% 
had no epithelial dysplasia (Table XIV). Of all the leukoplakic lesions with epithelial 
dysplasia, 67% had mild epithelial dysplasia, 31% had moderate epithelial dysplasia and 
2% had severe epithelial dysplasia. The degree of dysplasia was not significantly 
associated with tobacco associated leukoplakia or the clinical type, but it was significantly 
associated with the oral site involved (floor of the mouth, ventrolateral surface of the 
tongue, p-value< 0.05). 
 
Interpretation of the results of different studies with regard to the relation between 
epithelial dysplasia and different parameters of oral leukoplakia needs to be done with 
caution since the exercise of grading epithelial dysplasia is highly subjective with low 
interpersonal reproducibility (7, 50).  
 
This study has two main limitations.  Firstly, it is a retrospective study; and secondly it is 
based on archived histopathological reports.  Most importantly the number of black 
persons was small, not giving optimal statistical strength to the results.  However, despite 
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these limitations this study provides some important differences in the clinicopathological 
features of oral leukoplakia between black persons and white persons. 
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CHAPTER 7 
 
7. CONCLUSION 
 
In keeping with the prime objective of this study, the clinicopathological features of oral 
leukoplakia were defined in the different racial groups in the greater Johannesburg area of 
South Africa, and especially in the black population.  
 
As mentioned previously, only 14% of oral leukoplakia occurred in black persons 
compared to 80% in white persons.  In contrast to white persons, black persons were 
diagnosed with oral leukoplakia at a younger age; there were more males affected than 
females; and the proportion of idiopathic leukoplakias was greater.  There were 
significantly more black people (23%) with non-homogenous leukoplakia oral leukoplakia 
than white people with non-homogenous leukoplakia (13%), but there were significantly 
more white people (51%) than black people (23%) with dysplastic oral leukoplakia; and 
while in white people the floor of the mouth was the most frequently affected site, in black 
people it was the buccal mucosa. 
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APPENDIX 
1: Data collection form 
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2: Ethics clearance certificate  
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3: Permission letter  
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